Home › Funds › Ishara Investments LP › LXRX
Ishara Investments LP position in LXRX
LEXICON PHARMACEUTICALS INC · Health Care
Ishara Investments LP reported holding 320,000 shares of LXRX (LEXICON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$600K, representing 0.51% of its reported portfolio and ranking #37 among its reported holdings. Ishara Investments LP has disclosed LXRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ishara Investments LP's LXRX position evolved
Ishara Investments LP first disclosed a stake in LXRX in Q4 2025 at 880,000 shares (US$1.0M). The position peaked in Q2 2026 at 1,271,000 shares, worth US$3.1M. Across 4 filings, Ishara Investments LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 320,000 shares valued at US$600K — a reduction of -951,000 shares quarter over quarter.. Notable position changes include a 41% increase in Q2 2026 (shares fell 22% over the following quarter), a 75% trim in Q3 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 880.00K | $1.01M | New |
| Q1 2026 | 902.00K | $1.41M | Add |
| Q2 2026 | 1.27M | $3.05M | Add |
| Q3 2026 | 320.00K | $600.00K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LXRX and 13F data
LXRX (LEXICON PHARMACEUTICALS INC) is a Health Care company. 26 other funds we track also report a position in LXRX — the largest reported positions include Artal Group S.A. (US$329.3M), Siren, L.L.C. (US$83.3M), Sessa Capital IM, L.P. (US$45.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LXRX
- Artal Group S.A. 175.16M sh · $329.29M · Q3 2026
- Siren, L.L.C. 44.30M sh · $83.29M · Q3 2026
- Sessa Capital IM, L.P. 18.96M sh · $45.51M · Q2 2026
More on Ishara Investments LP
FAQ
How long has Ishara Investments LP held LXRX?
Ishara Investments LP has disclosed LXRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Ishara Investments LP's current position in LXRX?
As of Q3 2026, Ishara Investments LP holds 320.00K shares of LXRX (LEXICON PHARMACEUTICALS INC), valued at $600.00K, representing 0.51% of its reported portfolio and ranking #37.
Has Ishara Investments LP been buying or selling LXRX?
In the latest 13F filing (Q3 2026), Ishara Investments LP reduced its position in LXRX. The position peaked in Q2 2026 at 1.27M shares.
Which other funds hold LXRX?
Other major institutional holders of LXRX include Artal Group S.A., Siren, L.L.C., Sessa Capital IM, L.P., among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.